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SUMMARY. The present study utilizes approach of solid dispersions (SDs) to improve dissolution rate of
Gliclazide (GLZ); a poorly water soluble anti-diabetic drug. Formulations were prepared by solvent
evaporation and melt dispersion techniques using poloxamer as hydrophilic carriers. SDs and physical
mixtures (PM) were characterized by thin layer chomatography, FTIR spectroscopy, X-Ray Diffractome-
try, and Differential Scanning Calorimetry. TLC was used to identify any possibility of degradation dur-
ing preparation and optimize melting temperature for melt dispersion batches, which was supported by
FTIR and DSC, showing absence of chemical interaction between the drug and carrier. XRD showed that
GLZ was converted to amorphous form. Enhancement in dissolution was found more prominent with
melt dispersions compared to solvent evaporation and physical mixtures. In vivo pharmacodynamic
bioavailability study was performed for 28 days on alloxan induced diabetic wistar rats. Blood glucose
levels were evidently lowered and controlled by SD compared to GLZ alone.
